Fujifilm to restart clinical trial of Avigan for treatment

21/02/2021

Fujifilm Holdings Corp will restart a clinical trial in Japan of its antiviral drug Avigan for the treatment of the virus, the Nikkei newspaper reported.

Domestic approval of the drug was delayed after a health ministry panel said in December that trial data was inconclusive. The new study will involve about 270 patients and Fujifilm will aim to seek approval again in October, Nikkei said.

Category:

Articles like this